Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy.
Liu Y, Ma Q, Yang K, Zhang D, Li F, Chen J, Zhou F, Wang H, Li N, Wang Y, Cao Y, Zhang C, Li X, Zhang H, Wang W, Li Y.
Liu Y, et al. Among authors: li f, li y, li x, li n.
Biochem Biophys Res Commun. 2024 Feb 26;698:149546. doi: 10.1016/j.bbrc.2024.149546. Epub 2024 Jan 18.
Biochem Biophys Res Commun. 2024.
PMID: 38266314